| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.5 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.5 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |